An investigational drug for multiple sclerosis from Io Therapeutics has restored leg mobility and myelin nerve coatings in ...

The mouse is capable of producing humanized mAbs ... for psoriasis are with Johnson & Johnson's Centocor Ortho Biotech unit in Horsham, Pennsylvania. The third partnership is with Basel-based ...

Market Growth: The humanized mouse model market is forecasted to grow from USD 101.5 million in 2023 to USD 178.3 million by ...

The data suggests that Hmga1, a key protein for regenerating heart cells, could be a target for gene therapies that prevent cardiac failure.

The mouse model carrying Dyrk1a I48K truncation mutation (a human patient mutation), also mimics these phenotypes closely. One of the underlying mechanisms of ASD symptoms by Dyrk1a mutation ...